(EMAILWIRE.COM, July 08, 2010 ) Cheyenne, WY - A leading U.S. biotech organisation creating pharmaceutical cannabis goods is glad to announce it has signed a long-term lease for a facility of 9,500 square foot in Denver, Colorado. This will become the research facility as well as the corporate office for producing, testing and developing cannabis for patients in agreement with the laws governing in the state Colorado regarding medical marijuana. The CEO and President of the Cannabis Science (OTCBB:CBIS) stated that this facility would greatly benefit them by increasing their ability to provide affordable medicine based of cannabis to various patients. However, the 52-week high and the 52-week low were at 1.440 and 0.056 respectively. The average volume was marked at 313,300.

TheOTCmarket.com offers Stock Newsletter on various hot stocks of the day.

We also offer a news alert service on twitter by following our twits at http://twitter.com/theOTCmarket

We publish daily news in the form of our Market Snapshot and also provide daily Hot Stocks for its visitors. Additional attractions for investors and financial institutions are offered in the form of stock alerts, newsletters and other forms of subscribed information.

You can become leader in stock market by keeping track of the daily activity.

Disclaimer:
THEOTCM electronically disseminates information (the “Information”) on its websites, in newsletters, featured reports, spam compliant double-opt in email communications or otherwise pertaining to Featured Stocks’ (the “Issuer” or “Issuers” or “Featured Stock” or “Featured Stocks”), the securities of which are most frequently common stock shares quoted on the Over the Counter Bulletin Board (“OTCBB”) or Pink Sheets. The Information is based on publicly available information, such as quarterly (with unaudited financial statements) and annual reports (with audited financial statements) filed with the Securities and Exchange Commission (“SEC”), quarterly and annual unaudited financial reports and Information and Disclosure Statements filed with the Pink Sheets, the Issuer’s website and information obtained through search engines such as Yahoo Finance, Market Watch, PRnewswire, StockHouse, StockWatch, OTCmarket and Business Wire. We synthesize the Information from these informational sources for our Readers as a starting point for further inquiry into the Issuer and its securities.

THEOTCM is not a registered investment advisor or registered securities broker dealer and the Information should not be construed in any manner, shape or form as investment advice, investment recommendations or opinions or viewpoints regarding the Profiled Company or its securities or as a solicitation to offer, purchase or sell the Profiled Company’s securities.   THEOTCM does not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information and conducts no due diligence whatsoever of the Profiled Companies.  Because the Information is presented on an “as is” basis, your use of the Information is at your own risk.  THEOTCM  disclaims, expressly and impliedly, all warranties of any kind, including those of  merchantability and fitness for a particular purpose or whether the Information is accurate or reliable or  free of errors.  The Reader hereby indemnifies THEOTCM from any liability for any claimed direct, indirect, incidental, punitive, or consequential damages pertaining to the disseminated Information.

###
Press release services and press release distribution by EmailWire.Com:
http://www.emailwire.com/us-press-release-distribution.php .

Contact Information:
TheOTCmarket.com
Peter Lee
Tel: 1-307-633-9869
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.